Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on June 14, 2017, primarily to reaffirm its financial guidance for the full year 2017. The company informed investors that it expects net income to be greater than $10.37 per share, which includes an anticipated $1.23 per share in net unfavorable items. Excluding these items, the adjusted net income guidance remains strong, with the company expecting it to exceed $11.60 per share. This guidance is consistent with the information provided in the company's first quarter 2017 earnings release and does not incorporate any new adjustment items.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) reaffirmed its full-year 2017 net income guidance.
- 2Projected net income for full year 2017 is expected to be greater than $10.37 per share.
- 3Anticipated net unfavorable items for 2017 are projected to be greater than $1.23 per share.
- 4Adjusted net income guidance for full year 2017 is expected to exceed $11.60 per share.
- 5The guidance reaffirmed does not include any adjustment items beyond those reported in the Q1 2017 earnings release.
- 6The information was shared in the context of upcoming investor meetings scheduled between June 14 and June 30, 2017.
Frequently Asked Questions
The primary purpose of this 8-K filing is for Elevance Health (then Anthem, Inc.) to reaffirm its financial guidance for the full year 2017 to investors during meetings scheduled in June 2017. It confirms their projected net income and adjusted net income figures.
The company expects its net income for the full year 2017 to be greater than $10.37 per share. This figure accounts for certain net unfavorable items.
The company anticipates net unfavorable items of greater than $1.23 per share for the full year 2017. Excluding these specific items, the adjusted net income is projected to be higher.
Yes, the adjusted net income guidance excludes specific unfavorable items. Elevance Health expects its adjusted net income for the full year 2017 to be greater than $11.60 per share.